3,068 research outputs found

    Design and fabrication of SNAP-8 auxiliary loop heat exchangers Final report

    Get PDF
    Design and fabrication of prototype auxiliary loop heat exchanger for SNAP

    Investigating Detroit Water Shutoffs and Hepatitis A

    Get PDF
    Introduction: Hepatitis A (HAV) is a self-limiting viral liver disease that can manifest as abdominal pain, anorexia, nausea, fatigue, and jaundice with elevated serum aminotransferase levels. Despite an efficacious vaccine, there has been an outbreak across the country, including metropolitan Detroit. Recent cases in Michigan have presented with severe life-threatening manifestations. Already, 905 cases of hepatitis A have been reported in Michigan in the months of September and October 2018, of which 726 have resulted in hospitalization (80.2%) and 28 deaths. The historical notion of transmission fecal-orally via food is now more complex, as higher risk populations include those using drugs and those experiencing homelessness. This study evaluated risk factors for hepatitis A in an epidemic setting in urban Detroit including potential association with Detroit mandated water shutoff. Methods: Patients who received care at Henry Ford Health System between August 2016 and December 2017 with positive hepatitis A diagnoses were selected if their electronic medical record (EMR) indicated their home addresses within Detroit city proper. Patients were contacted via telephone numbers listed in the EMR and asked for voluntary phone interview participation. Patients were asked a standardized set of questions. This study was approved by the Henry Ford Hospital Institutional Review Board. Results: Sixty-six Detroit patients with Hepatitis A were reviewed. Twenty-two were available for contact and agreed to phone interview. Thirteen of the 22 were male (59.1%). Average age was 49, ranging from 21 to 81 years of age. Three (13.6%) had a history of intravenous drug use; two (9.1%) were food handlers; and four (14.2%) were homeless. Three patients (13.6%) were discovered deceased upon phone interview with a family member and fourteen (63.6%) were hospitalized, according to hospital records. Of note, four patients (14.2%) had their water shut off. Conclusion: Recent data from the CDC demonstrates a new trend of hepatitis A infections among persons reporting injection or non-injection drug use or homelessness. This study evaluated risk factors for hepatitis A in an epidemic setting in urban Detroit including potential association with Detroit-mandated water shutoffs. It is worth investigating the importance of water shutoffs and homelessness among hepatitis A outbreaks, as those who are homeless often lack access to clean water. This public health crisis continues despite a HAV vaccine being readily available and efficacious, warranting further investigation as to the source.https://scholarlycommons.henryford.com/merf2019clinres/1062/thumbnail.jp

    A Hemoglobin-Based Multifunctional Therapeutic: Polynitroxylated Pegylated Hemoglobin

    Get PDF
    Polynitroxylated pegylated hemoglobin (PNPH) as a multifunctional therapeutic takes advantage of the ability of hemoglobin (Hb) to transport oxygen, the antioxidative stress activities from the redox coupling of nitroxide and heme iron, and the hypercolloid properties of pegylation. The published preclinical data demonstrating that PNPH acts as a neurovascular protective multifunctional therapeutic in an animal model simulating prehospital resuscitation of traumatic brain injury (TBI) with hemorrhagic shock (HS) are reviewed. Preliminary results on the potential utility of PNPH for neurovascular protection in thrombolytic stroke therapy and for correction of vascular dysfunction through transfusion in sickle-cell disease (SCD) are also discussed. We hypothesize that with PNPH, Hb has more than been tamed--it has become a therapeutic and not just a nontoxic extracellular oxygen carrier--and that successful PNPH development as a multifunctional therapeutic that protects the neurovasculature and reduces oxidative stress may represent a paradigm shift in transfusion and critical care medicine, which may meet a number of unmet medical needs resulting from oxidative stress and inadequate blood flow, such as HS, TBI, SCD, and stroke

    Effect of alendronate on post-traumatic osteoarthritis induced by anterior cruciate ligament rupture in mice.

    Get PDF
    IntroductionPrevious studies in animal models of osteoarthritis suggest that alendronate (ALN) has antiresorptive and chondroprotective effects, and can reduce osteophyte formation. However, these studies used non-physiologic injury methods, and did not investigate early time points during which bone is rapidly remodeled prior to cartilage degeneration. The current study utilized a non-invasive model of knee injury in mice to investigate the effect of ALN treatment on subchondral bone changes, articular cartilage degeneration, and osteophyte formation following injury.MethodsNon-invasive knee injury via tibial compression overload or sham injury was performed on a total of 90 mice. Mice were treated with twice weekly subcutaneous injections of low-dose ALN (40 Î¼g/kg/dose), high-dose ALN (1,000 Î¼g/kg/dose), or vehicle, starting immediately after injury until sacrifice at 7, 14 or 56 days. Trabecular bone of the femoral epiphysis, subchondral cortical bone, and osteophyte volume were quantified using micro-computed tomography (μCT). Whole-joint histology was performed at all time points to analyze articular cartilage and joint degeneration. Blood was collected at sacrifice, and serum was analyzed for biomarkers of bone formation and resorption.ResultsμCT analysis revealed significant loss of trabecular bone from the femoral epiphysis 7 and 14 days post-injury, which was effectively prevented by high-dose ALN treatment. High-dose ALN treatment was also able to reduce subchondral bone thickening 56 days post-injury, and was able to partially preserve articular cartilage 14 days post-injury. However, ALN treatment was not able to reduce osteophyte formation at 56 days post-injury, nor was it able to prevent articular cartilage and joint degeneration at this time point. Analysis of serum biomarkers revealed an increase in bone resorption at 7 and 14 days post-injury, with no change in bone formation at any time points.ConclusionsHigh-dose ALN treatment was able to prevent early trabecular bone loss and cartilage degeneration following non-invasive knee injury, but was not able to mitigate long-term joint degeneration. These data contribute to understanding the effect of bisphosphonates on the development of osteoarthritis, and may support the use of anti-resorptive drugs to prevent joint degeneration following injury, although further investigation is warranted
    • …
    corecore